Correlation Between Bionoid Pharma and Medipharm Labs
Can any of the company-specific risk be diversified away by investing in both Bionoid Pharma and Medipharm Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bionoid Pharma and Medipharm Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bionoid Pharma and Medipharm Labs Corp, you can compare the effects of market volatilities on Bionoid Pharma and Medipharm Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bionoid Pharma with a short position of Medipharm Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bionoid Pharma and Medipharm Labs.
Diversification Opportunities for Bionoid Pharma and Medipharm Labs
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Bionoid and Medipharm is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Bionoid Pharma and Medipharm Labs Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medipharm Labs Corp and Bionoid Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bionoid Pharma are associated (or correlated) with Medipharm Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medipharm Labs Corp has no effect on the direction of Bionoid Pharma i.e., Bionoid Pharma and Medipharm Labs go up and down completely randomly.
Pair Corralation between Bionoid Pharma and Medipharm Labs
Given the investment horizon of 90 days Bionoid Pharma is expected to under-perform the Medipharm Labs. In addition to that, Bionoid Pharma is 6.03 times more volatile than Medipharm Labs Corp. It trades about -0.02 of its total potential returns per unit of risk. Medipharm Labs Corp is currently generating about -0.07 per unit of volatility. If you would invest 5.40 in Medipharm Labs Corp on August 29, 2024 and sell it today you would lose (0.40) from holding Medipharm Labs Corp or give up 7.41% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bionoid Pharma vs. Medipharm Labs Corp
Performance |
| Timeline |
| Bionoid Pharma |
| Medipharm Labs Corp |
Bionoid Pharma and Medipharm Labs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bionoid Pharma and Medipharm Labs
The main advantage of trading using opposite Bionoid Pharma and Medipharm Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bionoid Pharma position performs unexpectedly, Medipharm Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medipharm Labs will offset losses from the drop in Medipharm Labs' long position.| Bionoid Pharma vs. Braskem SA Class | Bionoid Pharma vs. GMS Inc | Bionoid Pharma vs. Air Products and | Bionoid Pharma vs. National Vision Holdings |
| Medipharm Labs vs. Green Cures Botanical | Medipharm Labs vs. Cann American Corp | Medipharm Labs vs. Rimrock Gold Corp | Medipharm Labs vs. Galexxy Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |